Active substance
Gonadotrophin chorionic human
- SFDA 9
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CHORIOMON 5000 I.U VIAL+AMP OF SOLVENT | 5000 IU | Injection · Intramuscular use | 3 Vial | SAR 142.30 | Biological · Prescription | IBSA INSTITUTE BIOCHIMIQUE S.A | Valid |
| EPIFASI 5000 IU LYOPHILIZED POWDER FOR I.M. Injection* | 5000 IU | Powder for injection · Intramuscular use | 1 Ampoule | SAR 27.15 | Biological · Prescription | EIPICO | Valid |
| CHORAPUR 5000IU powder and solvent for solution for injection | 5000 IU | Powder and solvent for solution for injection · Intramuscular use | 3 Vial | SAR 142.30 | Biological · Prescription | FERRING | Withdrawn by MAH · Not Marketed |
| CHORIOMON 1000 I.U VIAL+AMP OF SOLVENT | 100 IU | Injection · Intramuscular use | 3 Vial | SAR 15.70 | Biological · Prescription | IBSA INSTITUTE BIOCHIMIQUE S.A | Withdrawn by MAH · Not Marketed |
| PRIMOGONYL 1000 I.U AMP | 1000 IU | Injection · Intramuscular use | 3 Ampoule | SAR 40.35 | Biological · Prescription | BAYER SCHERING PHARMA | Withdrawn by MAH · Not Marketed |
| PRIMOGONYL 5000-1.U. AMP | 5000 IU | Injection · Intramuscular use | 3 Ampoule | SAR 76.10 | Biological · Prescription | BAYER SCHERING PHARMA | Withdrawn by MAH · Not Marketed |
| PROFASI AMP 1000 I.U.+SOLVENT | 1000 IU | Injection · Intramuscular use | 3 Ampoule | SAR 16.85 | Biological · Prescription | SERONO | Withdrawn by MAH · Not Marketed |
| PROFASI AMP 500 I.U+SOLVENT | 500 IU | Injection · Intramuscular use | 3 Ampoule | SAR 14.05 | Biological · Prescription | SERONO | Withdrawn by MAH · Not Marketed |
| PROFASI AMP 5000 I.U.+SOLVENT | 5000 IU | Injection · Intramuscular use | 3 Ampoule | SAR 50.20 | Biological · Prescription | SERONO | Withdrawn by MAH · Not Marketed |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.